Corneal cross-linking with riboflavin for keratoconus: update of clinical and cost-effectiveness
CADTH
Record ID 32016000185
English
Authors' recommendations:
One systematic review and meta-analysis, one randomized controlled trial, and 10 non-randomized studies were identified regarding the clinical effectiveness of corneal collagen cross-linking for patients with keratoconus and other corneal thinning disorders. No relevant cost-effectiveness literature was identified.
Details
Project Status:
Completed
Year Published:
2014
URL for published report:
http://www.cadth.ca/sites/default/files/pdf/htis/dec-2014/RA0712%20Corneal%20Collagen%20Cross-Linking%20Final.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Corneal Diseases
- Cross-Linking Reagents
Contact
Organisation Name:
Canadian Agency for Drugs and Technologies in Health
Contact Address:
600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name:
requests@cadth.ca
Contact Email:
requests@cadth.ca
Copyright:
Canadian Agency for Drugs and Technologies in Health (CADTH)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.